MicroRNA-218 increases cellular sensitivity to Rapamycin via targeting Rictor in cervical cancer.

Li J, Li X, Wang J, Wang Y, Qiu H

Open source

DOI
10.1111/apm.12387
Published
2015 Jul
Container
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/apm.12387,
  title = {MicroRNA-218 increases cellular sensitivity to Rapamycin via targeting Rictor in cervical cancer.},
  author = {Li J and Li X and Wang J and Wang Y and Qiu H},
  year = {2015},
  journal = {APMIS : acta pathologica, microbiologica, et immunologica Scandinavica},
  doi = {10.1111/apm.12387},
  url = {https://doi.org/10.1111/apm.12387}
}

RIS

TY  - JOUR
TI  - MicroRNA-218 increases cellular sensitivity to Rapamycin via targeting Rictor in cervical cancer.
AU  - Li J
AU  - Li X
AU  - Wang J
AU  - Wang Y
AU  - Qiu H
PY  - 2015
JO  - APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
DO  - 10.1111/apm.12387
UR  - https://doi.org/10.1111/apm.12387
ER  - 

APA

J, L., X, L., J, W., Y, W., & H, Q. (2015). MicroRNA-218 increases cellular sensitivity to Rapamycin via targeting Rictor in cervical cancer.. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. https://doi.org/10.1111/apm.12387

Source records